143 related articles for article (PubMed ID: 18458088)
1. Cdc34-mediated degradation of ATF5 is blocked by cisplatin.
Wei Y; Jiang J; Liu D; Zhou J; Chen X; Zhang S; Zong H; Yun X; Gu J
J Biol Chem; 2008 Jul; 283(27):18773-81. PubMed ID: 18458088
[TBL] [Abstract][Full Text] [Related]
2. Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis.
Pati D; Meistrich ML; Plon SE
Mol Cell Biol; 1999 Jul; 19(7):5001-13. PubMed ID: 10373550
[TBL] [Abstract][Full Text] [Related]
3. Cadmium interferes with the degradation of ATF5 via a post-ubiquitination step of the proteasome degradation pathway.
Uekusa H; Namimatsu M; Hiwatashi Y; Akimoto T; Nishida T; Takahashi S; Takahashi Y
Biochem Biophys Res Commun; 2009 Mar; 380(3):673-8. PubMed ID: 19285020
[TBL] [Abstract][Full Text] [Related]
4. Processive ubiquitin chain formation by the anaphase-promoting complex.
Meyer HJ; Rape M
Semin Cell Dev Biol; 2011 Aug; 22(6):544-50. PubMed ID: 21477659
[TBL] [Abstract][Full Text] [Related]
5. Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells.
Liu X; Liu D; Qian D; Dai J; An Y; Jiang S; Stanley B; Yang J; Wang B; Liu X; Liu DX
J Biol Chem; 2012 Jun; 287(23):19599-609. PubMed ID: 22528486
[TBL] [Abstract][Full Text] [Related]
6. ATF5 increases cisplatin-induced apoptosis through up-regulation of cyclin D3 transcription in HeLa cells.
Wei Y; Jiang J; Sun M; Chen X; Wang H; Gu J
Biochem Biophys Res Commun; 2006 Jan; 339(2):591-6. PubMed ID: 16300731
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-conjugating enzyme Cdc34 mediates cadmium resistance in budding yeast through ubiquitination of the transcription factor Met4.
Hwang GW; Furuchi T; Naganuma A
Biochem Biophys Res Commun; 2007 Nov; 363(3):873-8. PubMed ID: 17904100
[TBL] [Abstract][Full Text] [Related]
8. Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression.
Sadowski M; Mawson A; Baker R; Sarcevic B
Biochem J; 2007 Aug; 405(3):569-81. PubMed ID: 17461777
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34.
Petroski MD; Deshaies RJ
Cell; 2005 Dec; 123(6):1107-20. PubMed ID: 16360039
[TBL] [Abstract][Full Text] [Related]
10. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.
Van Sant C; Hagglund R; Lopez P; Roizman B
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8815-20. PubMed ID: 11447293
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase Skp1-cullin-F-box ligase (SCF) interact through multiple conformations.
Sandoval D; Hill S; Ziemba A; Lewis S; Kuhlman B; Kleiger G
J Biol Chem; 2015 Jan; 290(2):1106-18. PubMed ID: 25425648
[TBL] [Abstract][Full Text] [Related]
12. The acidic tail domain of human Cdc34 is required for p27Kip1 ubiquitination and complementation of a cdc34 temperature sensitive yeast strain.
Block K; Appikonda S; Lin HR; Bloom J; Pagano M; Yew PR
Cell Cycle; 2005 Oct; 4(10):1421-7. PubMed ID: 16123592
[TBL] [Abstract][Full Text] [Related]
13. SCF E3-mediated autoubiquitination negatively regulates activity of Cdc34 E2 but plays a nonessential role in the catalytic cycle in vitro and in vivo.
Scaglione KM; Bansal PK; Deffenbaugh AE; Kiss A; Moore JM; Korolev S; Cocklin R; Goebl M; Kitagawa K; Skowyra D
Mol Cell Biol; 2007 Aug; 27(16):5860-70. PubMed ID: 17562869
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-conjugating enzyme Cdc34 mediates methylmercury resistance in Saccharomyces cerevisiae by increasing Whi2 degradation.
Hwang GW; Ogiwara Y; Takahashi T; Naganuma A
J Toxicol Sci; 2012; 37(6):1283-6. PubMed ID: 23208445
[TBL] [Abstract][Full Text] [Related]
15. FBXO15 regulates P-glycoprotein/ABCB1 expression through the ubiquitin--proteasome pathway in cancer cells.
Katayama K; Noguchi K; Sugimoto Y
Cancer Sci; 2013 Jun; 104(6):694-702. PubMed ID: 23465077
[TBL] [Abstract][Full Text] [Related]
16. Essential role for ubiquitin-ubiquitin-conjugating enzyme interaction in ubiquitin discharge from Cdc34 to substrate.
Saha A; Lewis S; Kleiger G; Kuhlman B; Deshaies RJ
Mol Cell; 2011 Apr; 42(1):75-83. PubMed ID: 21474069
[TBL] [Abstract][Full Text] [Related]
17. SUMO2/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome.
Yuan Y; Gaither K; Kim E; Liu E; Hu M; Lengel K; Qian D; Xu Y; Wang B; Knipprath H; Liu DX
J Biol Chem; 2018 Feb; 293(8):2939-2948. PubMed ID: 29326161
[TBL] [Abstract][Full Text] [Related]
18. The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels.
Butz N; Ruetz S; Natt F; Hall J; Weiler J; Mestan J; Ducarre M; Grossenbacher R; Hauser P; Kempf D; Hofmann F
Exp Cell Res; 2005 Feb; 303(2):482-93. PubMed ID: 15652359
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress responses involve oxidation of a conserved ubiquitin pathway enzyme.
Doris KS; Rumsby EL; Morgan BA
Mol Cell Biol; 2012 Nov; 32(21):4472-81. PubMed ID: 22949505
[TBL] [Abstract][Full Text] [Related]
20. Direct characterization of E2-dependent target specificity and processivity using an artificial p27-linker-E2 ubiquitination system.
Ryu KS; Choi YS; Ko J; Kim SO; Kim HJ; Cheong HK; Jeon YH; Choi BS; Cheong C
BMB Rep; 2008 Dec; 41(12):852-7. PubMed ID: 19123975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
